Stocktoria
Bone Biologics Corp BBLG
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-11-27
Bone Biologics Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | -0.1% | -0.2% | — | -0.3% | — |
| Net margin | — | — | — | — | — | -0.2% | -0.3% | — | -0.4% | — |
| Return on assets | -53.6% | -106.5% | -239.4% | -17.5% | -24.1% | — | -11109.8% | — | -425.7% | — |
| Return on equity | -57.8% | -118.0% | -307.9% | -25.0% | -24.5% | 13.3% | 28.9% | — | 51.5% | — |
| Current ratio | 13.85 | 10.22 | 4.50 | 3.33 | — | — | 0.05 | 0.08 | 0.11 | 4.48 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.